SAN FRANCISCO--(BUSINESS WIRE)--Fluxion Biosciences, a leading developer of microfluidic systems for cellular analysis in life sciences research and drug discovery, today announced that it has signed a distribution agreement with AutoMate Scientific. The distribution agreement covers Fluxion’s BioFlux™ platform for studying cellular interactions. Fluxion’s BioFlux system offers researchers a powerful analysis tool for the study of biofilms and cellular adhesion.

Biofilms are layers of live bacteria which form when they adhere to surfaces inside the body. These microbes can become a thousand times more resistant to anti-bacterial medication once in the biofilm state. Biofilms are implicated in a wide range of diseases, including cystic fibrosis, pneumonia, and oral infections. Fluxion’s BioFlux system is used to screen potential medications that can prevent biofilm formation. It is also used as a research tool to discover the principal mechanisms of how biofilms form, propagate, and ultimately get eradicated.

Cell adhesion is a fundamental process in the human immune response. Medications which can modulate the cell adhesion process have the potential to improve the lives of people suffering from a number of diseases, including rheumatoid arthritis, cardiovascular diseases, and cancer. Fluxion’s BioFlux system provides an automated, high throughput platform for studying cell adhesion processes and developing effective treatments for these critical diseases.

“AutoMate Scientific is an ideal partner to distribute the BioFlux system. They have developed a well-deserved reputation for delivering top-quality products and service to their customer base,” notes Mike Schwartz, Product Manager for BioFlux systems at Fluxion Biosciences.

“We are excited to distribute Fluxion’s BioFlux System,” states Joe Cordes, President of AutoMate Scientific. “We have a strong presence in the life science research market and the BioFlux platform makes an excellent addition to our other cellular research tools.”

AutoMate Scientific’s distribution agreement is effective immediately and products can be ordered directly from the AutoMate Scientific website (www.autom8.com).

About Fluxion Biosciences

Fluxion Biosciences develops cellular analysis tools for use in critical applications in life sciences research and drug discovery. Fluxion’s proprietary microfluidic platform, CellFlux, enables precise functional analysis of individual cells in a highly multiplexed format. Products include the BioFlux System for biofilm and cellular adhesion assays, IonFlux System for cellular electrophysiology, and the CytoFlux System for stop-flow imaging cytometry. These products meet the rigorous demands of life science and drug discovery scientists by providing an intuitive, easy-to-use "operating system" for single-cell biology. For more information about Fluxion Biosciences, visit www.fluxionbio.com.

About AutoMate Scientific

AutoMate Scientific develops and distributes innovative research tools for cell biology research. Founded in 1992, AutoMate Scientific provides complete solutions for researchers in cellular imaging, electrophysiology, pharmacology, physiology, and biophysics. For more information about AutoMate Scientific, please visit www.autom8.com.